Peroxisome Proliferator-Activated Receptors: “Key” Regulators of Neuroinflammation after Traumatic Brain Injury
Figure 2
Working hypothesis of
PPAR-mediated mechanisms of neuroprotection after traumatic brain injury. The
neuropathological sequelae of head injury include the posttraumatic activation
of NFκB-dependent
inflammatory genes. The transcription of neuroinflammatory mediators in the
injured brain induces and perpetuates the intracranial inflammatory response
and leads to formation of brain edema and adverse outcome. Activation of PPARs
by binding of synthetic ligands, such as the PPAR agonist fenofibrate, leads to inhibition of NFκB and of downstream transcribed proinflammatory
and proapoptotic mediators. In addition, cannabinoids have a dual
neuroprotective function, (1) by acting as ligands to PPARs and (2) by
inhibiting “key” mediators of neuroinflammation and apoptosis, such as tumor
necrosis factor (TNF). The combination therapy of synthetic PPAR agonists and
cannabinoids may represent the long sought pharmacological “golden bullet” for
the treatment of traumatic brain injury in the future.